Lian‐Ying Wu

685 total citations
19 papers, 552 citations indexed

About

Lian‐Ying Wu is a scholar working on Molecular Biology, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, Lian‐Ying Wu has authored 19 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Physiology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Lian‐Ying Wu's work include Coenzyme Q10 studies and effects (8 papers), Adenosine and Purinergic Signaling (5 papers) and Photosynthetic Processes and Mechanisms (4 papers). Lian‐Ying Wu is often cited by papers focused on Coenzyme Q10 studies and effects (8 papers), Adenosine and Purinergic Signaling (5 papers) and Photosynthetic Processes and Mechanisms (4 papers). Lian‐Ying Wu collaborates with scholars based in United States and China. Lian‐Ying Wu's co-authors include D. James Morré, Dorothy M. Morré, D. James Morré, Dorothy M. Morré, Pin Ju Chueh, F.L. Crane, Rita Barr, Andrew W. Bridge, Xiaodong Zhang and Andrew O. Brightman and has published in prestigious journals such as Biochemistry, Biochimica et Biophysica Acta (BBA) - Biomembranes and Archives of Biochemistry and Biophysics.

In The Last Decade

Lian‐Ying Wu

19 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lian‐Ying Wu United States 13 348 73 71 68 53 19 552
Jeffrey C. Baker United States 9 414 1.2× 81 1.1× 60 0.8× 18 0.3× 47 0.9× 13 764
Andrea Lisa Holme United Kingdom 14 440 1.3× 42 0.6× 41 0.6× 35 0.5× 62 1.2× 20 932
Nicola Sassi Italy 14 615 1.8× 33 0.5× 26 0.4× 69 1.0× 17 0.3× 18 844
Dorothy M. Morré United States 9 226 0.6× 57 0.8× 15 0.2× 36 0.5× 41 0.8× 14 334
M. Dardalhon France 16 510 1.5× 21 0.3× 117 1.6× 25 0.4× 32 0.6× 37 872
Patricia M. Sokolove United States 18 803 2.3× 12 0.2× 68 1.0× 74 1.1× 80 1.5× 42 1.1k
Rosario I. Bello Spain 13 390 1.1× 13 0.2× 33 0.5× 12 0.2× 89 1.7× 20 633
Jingjing Zhuang China 15 345 1.0× 14 0.2× 88 1.2× 21 0.3× 33 0.6× 29 744
André R. Meinicke Brazil 8 330 0.9× 8 0.1× 45 0.6× 31 0.5× 33 0.6× 8 512
Michelle Pacholec United States 7 355 1.0× 120 1.6× 25 0.4× 40 0.6× 10 0.2× 7 870

Countries citing papers authored by Lian‐Ying Wu

Since Specialization
Citations

This map shows the geographic impact of Lian‐Ying Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lian‐Ying Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lian‐Ying Wu more than expected).

Fields of papers citing papers by Lian‐Ying Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lian‐Ying Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lian‐Ying Wu. The network helps show where Lian‐Ying Wu may publish in the future.

Co-authorship network of co-authors of Lian‐Ying Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Lian‐Ying Wu. A scholar is included among the top collaborators of Lian‐Ying Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lian‐Ying Wu. Lian‐Ying Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wu, Lian‐Ying, et al.. (2011). Metabolite modulation of HeLa cell response to ENOX2 inhibitors EGCG and phenoxodiol. Biochimica et Biophysica Acta (BBA) - General Subjects. 1810(8). 784–789. 6 indexed citations
2.
Zhang, Hang, Lian‐Ying Wu, Shuai Zhang, et al.. (2009). Anti‐Hepatitis B Virus X Protein in Sera Is One of the Markers of Development of Liver Cirrhosis and Liver Cancer Mediated by HBV. BioMed Research International. 2009(1). 289068–289068. 17 indexed citations
3.
Wu, Lian‐Ying, et al.. (2009). Numerical investigation of flow characteristics and irradiance history in a novel photobioreactor. AFRICAN JOURNAL OF BIOTECHNOLOGY. 8(18). 4672–4679. 11 indexed citations
4.
Zhang, Weiying, Lian‐Ying Wu, Ling Qiao, et al.. (2007). Involvement of hepatitis B X-interacting protein (HBXIP) in proliferation regulation of cells. Acta Pharmacologica Sinica. 28(3). 431–438. 38 indexed citations
5.
Ye, Lihong, Lian‐Ying Wu, Wei Guo, Hongtao Ma, & Xiaodong Zhang. (2006). [Screening of a sub-clone of human breast cancer cells with high metastasis potential].. PubMed. 86(1). 61–5. 13 indexed citations
6.
Ye, Lihong, Jiacong You, Wei Guo, et al.. (2006). [Investigation of discrepant proteins between two breast cancer cell lines with different metastatic abilities].. PubMed. 25(7). 823–7. 3 indexed citations
7.
Chueh, Pin Ju, Lian‐Ying Wu, Dorothy M. Morré, & D. James Morré. (2004). tNOX is both necessary and sufficient as a cellular target for the anticancer actions of capsaicin and the green tea catechin (-)-epigallocatechin-3-gallate.. PubMed. 20(4). 235–49. 48 indexed citations
8.
Morré, Dorothy M., et al.. (2003). Adriamycin tolerance in human mesothelioma lines and cell surface NADH oxidase. Life Sciences. 73(9). 1189–1198. 6 indexed citations
9.
Morré, D. James, et al.. (2002). Biochemical Basis for the Biological Clock. Biochemistry. 41(40). 11941–11945. 45 indexed citations
10.
11.
Morré, D. James, D. James Morré, Andrew W. Bridge, et al.. (2000). Preferential inhibition by (−)-epigallocatechin-3-gallate of the cell surface NADH oxidase and growth of transformed cells in culture. Biochemical Pharmacology. 60(7). 937–946. 75 indexed citations
12.
Morré, D. James, Lian‐Ying Wu, & Dorothy M. Morré. (1998). Response of a cell-surface NADH oxidase to the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N′-(4-chlorophenylurea) (LY181984) modulated by redox. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1369(2). 185–192. 13 indexed citations
13.
Morré, D. James, et al.. (1997). Inhibition of NADH oxidase activity and growth of HeLa cells by the antitumor sulfonylurea, N-(4-methylphenylsulfonyl)-N′-(4-chlorophenyl)urea (LY181984) and response to epidermal growth factor. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1355(2). 114–120. 9 indexed citations
14.
Morré, D. James, et al.. (1997). NADH Oxidase Activity from Sera Altered by Capsaicin Is Widely Distributed among Cancer Patients. Archives of Biochemistry and Biophysics. 342(2). 224–230. 67 indexed citations
15.
Wilkinson, Francis E., Chinpal Kim, Pin Ju Chueh, et al.. (1996). Isolation and Identification of a Protein with Capsaicin-Inhibited NADH Oxidase Activity from Culture Media Conditioned by Growth of HeLa Cells. Archives of Biochemistry and Biophysics. 336(2). 275–282. 29 indexed citations
16.
Morré, D. James, D. James Morré, Lian‐Ying Wu, Dorothy M. Morré, & Dorothy M. Morré. (1995). The antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N′-(4-chlorophenyl) urea (LY181984) inhibits NADH oxidase activity of HeLa plasma membranes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1240(1). 11–17. 51 indexed citations
17.
Morr�, D. J., et al.. (1994). Response to adriamycin of transplasma membrane electron transport in adriamycin-resistant and nonresistant HL-60 cells. Journal of Bioenergetics and Biomembranes. 26(1). 137–142. 5 indexed citations
18.
Morré, D. James, F.L. Crane, Rita Barr, Claude Penel, & Lian‐Ying Wu. (1988). Inhibition of plasma membrane redox activities and elongation growth of soybean. Physiologia Plantarum. 72(2). 236–240. 34 indexed citations
19.
Brightman, Andrew O., et al.. (1988). Role of plasma membrane redox activities in elongation growth in plants. Physiologia Plantarum. 73(1). 187–193. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey C. Baker Breakdown of academic impact, for papers by Andrea Lisa Holme Breakdown of academic impact, for papers by Nicola Sassi Breakdown of academic impact, for papers by Dorothy M. Morré Breakdown of academic impact, for papers by M. Dardalhon Breakdown of academic impact, for papers by Patricia M. Sokolove Breakdown of academic impact, for papers by Rosario I. Bello Breakdown of academic impact, for papers by Jingjing Zhuang Breakdown of academic impact, for papers by André R. Meinicke Breakdown of academic impact, for papers by Michelle Pacholec
Rankless by CCL
2026